Status:

COMPLETED

Arthroscopic Surgery and Platelet Rich Plasma In Rotator Cuff Tear Evaluation

Lead Sponsor:

McMaster University

Collaborating Sponsors:

Arthrex, Inc.

Conditions:

Rotator Cuff Tear

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

Rotator cuff tears are a common injury that lead to pain and loss of function for those who suffer from it. Treatment includes the use of arthroscopic surgery to return function to the patient and red...

Eligibility Criteria

Inclusion

  • Men or women who are between 18 and 70 years of age.
  • Primary, traumatic or degenerative rotator cuff tears measuring 3 cm or less.
  • Rotator cuff tears requiring arthroscopic repair within 18 months of initial diagnosis.
  • Provision of informed consent.

Exclusion

  • Rotator cuff tears secondary to a fracture.
  • Patients with an associated dislocation at the time of randomization.
  • Rotator cuff tears that underwent prior surgical repair or revision arthroscopy.
  • Non-surgical rotator cuff associated treatment in the 1 month prior to randomization including corticosteroid injection and anti-inflammatory treatment.
  • Prior platelet rich plasma injection.
  • Pre-existing conditions associated with upper extremity pain, including arthritis, ongoing infection, carpal tunnel syndrome, cervical neuropathy or other nerve pathology, local malignancy, and systemic disorders (e.g., uncontrolled diabetes, hypothyroidism).
  • Patients with gross shoulder instability.
  • Patients with an active infection.
  • Patients who are pregnant or plan to become pregnant in the next 12 months.
  • Patients with a pre-operative platelet count less than 125,000 and a pre-operative hemoglobin of 7.5g/dl or less.
  • Likely problems with follow-up (i.e. patients with no fixed address, report a plan to move out of town, or intellectually challenged patients without adequate family support).
  • Patients who do not read and speak English.
  • Patients participating in another ongoing trial that would interfere with the assessment of the primary or secondary outcomes.
  • Any other reason (in the judgment of the surgeon).

Key Trial Info

Start Date :

September 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2012

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT01170312

Start Date

September 1 2010

End Date

August 1 2012

Last Update

November 1 2012

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

McMaster University

Hamilton, Ontario, Canada, L8L8E7

2

Hamilton General Hospital

Hamilton, Ontario, Canada

3

McMaster Hospital

Hamilton, Ontario, Canada

Arthroscopic Surgery and Platelet Rich Plasma In Rotator Cuff Tear Evaluation | DecenTrialz